Content about Rilpivirine

September 22, 2011

J&J HIV drug shows fewer side effects in trial data analysis

A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.

August 11, 2011

FDA approves single-pill HIV drug

The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.

June 20, 2011

ReportersNotebook — Chain Pharmacy, 6/27/11

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

February 14, 2011

Gilead resubmits HIV drug application to FDA

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

July 21, 2010

Tibotec unveils efficacy results for investigational HIV drug

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

June 1, 2010

Decision Resources projects peak sales for three HIV drugs

Three new drugs for treating HIV from Gilead Sciences and J&J subsidiary Tibotec could have...